English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 858836      Online Users : 814
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    圖書 [1/1]
    會議論文/會議摘要 [10/11]
    專利 [0/24]

    Collection Statistics

    近3年內發表的文件:18(15.93%)
    含全文筆數:110(97.35%)

    文件下載次數統計
    下載大於0次:110(100.00%)
    下載大於100次:105(95.45%)
    檔案下載總次數:62313(92.25%)

    最後更新時間: 2024-11-28 22:33


    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-50 of 113. (3 Page(s) Totally)
    1 2 3 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2024-09-10 Boosting DNA vaccine power by lipid nanoparticles surface engineered with amphiphilic bioresorbable copolymer Molecular Therapy Nucleic Acids. 2024 Sep 10;35(3):Article number 102261.
    2024-03-14 Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamsters Molecular Therapy Methods and Clinical Development. 2024 Mar 14;32(1):Article number 101169.
    2024-03 Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy Nature Cancer. 2024 Mar;5(3):400-419.
    2024 ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression American Journal of Cancer Research. 2024;14(4):1850-1865.
    2023-12 A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethal Streptococcus pneumoniae challenge Emerging Microbes and Infections. 2023 Dec;12(2):Article number 2272656.
    2023-08-27 Co-delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1-dominant humoral and cellular immunity against SARS-CoV-2 Journal of Medical Virology. 2023 Aug 27;95(8):Article number e29040.
    2023-08-16 A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine Emerging Microbes and Infections. 2023 Aug 16;12(2):Article number 2249130.
    2023-08 Humoral and cellular immunity in three different types of COVID-19 vaccines against SARS-CoV-2 variants in a real-world data analysis Journal of Microbiology, Immunology and Infection. 2023 Aug;56(4):705-717.
    2023-06-02 Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types npj Vaccines. 2023 Jun 02;8:Article number 82.
    2023-05-29 TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses International Journal of Biological Sciences. 2023 May 29;19(9):2897-2913.
    2023-01-23 A flexible liposomal polymer complex as a platform of specific and regulable immune regulation for individual cancer immunotherapy Journal of Experimental and Clinical Cancer Research. 2023 Jan 23;42:Article number 29.
    2022-12-02 Omicron-specific mRNA vaccine induced cross-protective immunity against ancestral SARS-CoV-2 infection with low neutralizing antibodies Journal of Medical Virology. 2022 Dec 2;95:Article number e28370.
    2022-11-21 Formulation of SARS-CoV-2 spike protein with CpG oligodeoxynucleotides and squalene nanoparticles modulates immunological aspects following intranasal delivery Pharmaceutics. 2022 Nov 21;14(11):Article number 2539.
    2022-06-09 Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy Journal of Biomedical Science. 2022 Jun 9;29:Article number 37.
    2022-06-03 A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection npj Vaccines. 2022 Jun 03;7:Article number 60.
    2022-05-02 Furin and TMPRSS2 resistant spike induces robust humoral and cellular immunity against SARS-CoV-2 lethal infection Frontiers in Immunology. 2022 May 2;13:Article number 872047.
    2022-04-28 Low-dose SARS-CoV-2 S-trimer with an emulsion adjuvant induced th1-biased protective immunity International Journal of Molecular Sciences. 2022 Apr 28;23(9):Article number 4902.
    2022-04-22 Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants JCI Insight. 2022 Apr 22;7(8):Article number e157597.
    2021-10-11 Intranasal vaccination with recombinant antigen-FLIPr fusion protein alone induces long-lasting systemic antibody responses and broad T cell responses Frontiers in Immunology. 2021 Oct 11;12:Article number 751883.
    2021-10-05 A novel rapid test to detect anti-SARS-CoV-2 n protein IgG based on shear horizontal surface acoustic wave (SH-SAW) Diagnostics. 2021 Oct 5;11(10):Article number 1838.
    2021-10 Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment Journal for Immunotherapy of Cancer. 2021 Oct;9(10):Article number e002758.
    2021-09-25 Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19 International Journal of Pharmaceutics. 2021 Sep 25;607:Article number 121024.
    2021-09 Squalene nanoemulsion reinforces mucosal and immunological fingerprints following intravaginal delivery Biomedicine and Pharmacotherapy. 2021 Sep;141:Article number 111799.
    2021-08-11 Characterization of virus replication, pathogenesis, and cytokine responses in syrian hamsters inoculated with SARS-CoV-2 Journal of Inflammation Research. 2021 Aug 11;14:3781-3795.
    2021-07-12 A novel recombinant Fc gamma receptor-targeted survivin combines with chemotherapy for efficient cancer treatment Biomedicines. 2021 Jul 12;9(7):Article number 806.
    2021-05-27 DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss PLoS Neglected Tropical Diseases. 2021 May 27;15(5):Article number e0009374.
    2020-10-21 A polypeptide of tumor-associated antigen L6 with intrinsic adjuvant activity enhances antitumor immunity Vaccines. 2020 Oct 21;8(4):Article number 620.
    2020-10-09 Nanoemulsion adjuvantation strategy of tumor-associated antigen therapy rephrases mucosal and immunotherapeutic signatures following intranasal vaccination Journal for ImmunoTherapy of Cancer. 2020 Oct 9;8(2):Article number e001022.
    2020-04-14 Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice Journal of Biomedical Science. 2020 Apr 14;27:Article number 51.
    2020-04 Liposomal TLR9 agonist combined with TLR2 agonist-fused antigen can modulate tumor microenvironment through dendritic cells Cancers. 2020 Apr;12(4):Article number 810.
    2019-10 Domain 4 of pneumolysin from Streptococcus pneumoniae is a multifunctional domain contributing TLR4 activating and hemolytic activity Biochemical and Biophysical Research Communications. 2019 Oct;517(4):596-602.
    2019-09-01 Endoplasmic reticulum-targeting sequence enhanced the cellular immunity of a tumor-associated antigen L6-based DNA vaccine American Journal of Cancer Research. 2019 Sep 1;9(9):2028-2036.
    2019-08-02 Delivery of antigen to CD8(+) dendritic cells by fusing antigen with formyl peptide receptor-like 1 inhibitor protein induces antitumor immunity Frontiers in Immunology. 2019 Aug 2;10:Article number 1839.
    2019-04-11 Immunological evaluation of a novel HLA-A2 restricted phosphopeptide of tumor associated Antigen, TRAP1, on cancer therapy Vaccine: X. 2019 Apr 11;1:Article number 100017.
    2018-12 A therapeutic vaccine targeting HPV E6/E7 with intrinsic Toll-like receptor 2 agonist activity induces antitumor immunity American Journal of Cancer Research. 2018 Dec;8(12):2528-2537.
    2018-08 Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells EMBO Reports. 2018 Aug;19(8):Article number e46182.
    2018-04-23 Efficient uptake of recombinant lipidated survivin by antigen-presenting cells initiates antigen cross-presentation and antitumor immunity Frontiers in Immunology. 2018 Apr 23;9:Article number 822.
    2018-04-18 Polysorbasome: A colloidal vesicle contoured by polymeric bioresorbable amphiphiles as an immunogenic depot for vaccine delivery ACS Applied Materials and Interfaces. 2018 Apr 18;10(15):12553-12561.
    2017-03 Recent progress in GM-CSF-based cancer immunotherapy Immunotherapy. 2017 Mar;9(4):347-360.
    2016-12 Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer Oncotarget. 2016 Dec;7(52):85917-85928.
    2016-11-09 Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy Scientific Reports. 2016 Nov 09;6:Article number 36732.
    2016-07-29 Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice Scientific Reports. 2016 Jul 29;6:Article number 30648.
    2016-07 Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice Cancer Letters. 2016 Jul;377(2):126-133.
    2016-06 TGF-beta and IL-21 cooperatively stimulate activated CD8 T cells to differentiate into Tc17 cells Immunology Letters. 2016 Jun;174:23-27.
    2016-05-06 A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity Journal of Controlled Release. 2016 May 6;233:57-63.
    2016-05 A toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population Oncotarget. 2016 May;7(21):30804-30819.
    2016-04 Carboxyl-terminal fusion of E7 into Flagellin shifts TLR5 activation to NLRC4/NAIP5 activation and induces TLR5-independent anti-tumor immunity Scientific Reports. 2016 Apr;6:Article number 24199.
    2016-02 Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice Vaccine. 2016 Feb;34(8):1054-1061.
    2016-01 A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model Oncotarget. 2016 Jan;7(1):671-683.
    2015-12 Recombinant bacterial lipoproteins as vaccine candidates Expert Review of Vaccines. 2015 Dec;14(12):1623-1632.

    Showing items 1-50 of 113. (3 Page(s) Totally)
    1 2 3 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback